Description

This presentation advocates for non-invasive magnetic peripheral nerve stimulation (MPNS) as a first-line treatment for diabetic neuropathy-related pain. Traditional medications like gabapentin and pregabalin show limited effectiveness and high side effect rates. In contrast, recent prospective randomized studies using MPNS—especially with the Neuralace system—demonstrated sustained and significant pain relief (50–80% reduction in most patients) over 12 months, with high patient satisfaction and a low number needed to treat (1.4). The speaker compares MPNS to TENS, micro-TENS, and scrambler therapy, concluding that MPNS offers superior outcomes, is safe, and should be considered early in neuropathic pain management.